MX9305037A - Compuestos novedosos - Google Patents

Compuestos novedosos

Info

Publication number
MX9305037A
MX9305037A MX9305037A MX9305037A MX9305037A MX 9305037 A MX9305037 A MX 9305037A MX 9305037 A MX9305037 A MX 9305037A MX 9305037 A MX9305037 A MX 9305037A MX 9305037 A MX9305037 A MX 9305037A
Authority
MX
Mexico
Prior art keywords
alkyl
carbon atoms
hydrogen
compounds
novelty
Prior art date
Application number
MX9305037A
Other languages
English (en)
Inventor
Thomas Paul Blackburn
Ian Thomson Forbes
Roger Thomas Martin
Peter Ham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929217674A external-priority patent/GB9217674D0/en
Priority claimed from GB939306461A external-priority patent/GB9306461D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9305037A publication Critical patent/MX9305037A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Indole Compounds (AREA)

Abstract

Se describen compuestos de la fórmula (I): en donde: P representa un residuo quinolina o isoquinolina, o un anillo heterocíclico aromático de 5 o 6 miembros, que contiene hasta tres heteroátomos, seleccionados de nitrógeno, oxígeno o azufre; R1 es hidrógeno o alquilo de 1 a 6 átomos de carbono; R2, R3, R10 y R11 son independientes hidrógeno, alquilo de 1 a 6 átomos de carbono o R10 y R11 forman juntas una ligadura, o R2 y R10 o R3 y R11 forman juntas una cadena alquileno de 2 a 6 átomos de carbono; R4 es hidrógeno, alquilo de 1 a 6 átomos de carbono, halógeno, NR8R9 u OR12, en donde R8, R9 y R12 son independientemente hidrógeno o alquilo de 1 a 6 átomos de carbono; R5 es hidrógeno o alquilo de 1 a 6 átomos de carbono, OR12 o halógeno, en donde R12 es hidrógeno o alquilo de 1 a 6 átomos de carbono; n es 2 o 3; y los grupos R13 y R14 son independientemente hidrógeno o alquilo de 1 a 6 átomos de carbono; procedimientos para su preparación y su uso como medicamentos.
MX9305037A 1992-08-20 1993-08-18 Compuestos novedosos MX9305037A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929217674A GB9217674D0 (en) 1992-08-20 1992-08-20 Novel compounds
GB939306461A GB9306461D0 (en) 1993-03-29 1993-03-29 Novel compounds

Publications (1)

Publication Number Publication Date
MX9305037A true MX9305037A (es) 1994-03-31

Family

ID=26301461

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305037A MX9305037A (es) 1992-08-20 1993-08-18 Compuestos novedosos

Country Status (13)

Country Link
EP (1) EP0656003A1 (es)
JP (1) JPH08500580A (es)
CN (1) CN1086819A (es)
AP (1) AP9300560A0 (es)
AU (1) AU4704693A (es)
CA (1) CA2142721A1 (es)
IL (1) IL106737A0 (es)
MA (1) MA22955A1 (es)
MX (1) MX9305037A (es)
NZ (1) NZ254785A (es)
SI (1) SI9300438A (es)
TW (1) TW248557B (es)
WO (1) WO1994004533A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306460D0 (en) * 1993-03-29 1993-05-19 Smithkline Beecham Plc Novel compounds
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
GB9402542D0 (en) * 1994-02-10 1994-04-06 Smith Kline Beecham Plc Novel compounds
EP0757687A1 (en) * 1994-04-23 1997-02-12 Smithkline Beecham Plc Tricyclic derivatives as 5ht 2c? and 5ht 2b? antagonists
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
GB9420999D0 (en) * 1994-10-18 1994-12-07 Smithkline Beecham Plc Novel compounds
EA000304B1 (ru) * 1995-02-02 1999-04-29 Смитклайн Бичам Плс Производные индола как антагонисты рецептора 5-ht
WO1996023769A2 (en) * 1995-02-02 1996-08-08 Smithkline Beecham Plc Heterocyclic compounds possessing 5ht2c receptor antagonist activity
GB9517559D0 (en) * 1995-08-26 1995-10-25 Smithkline Beecham Plc Novel compounds
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
GB9612885D0 (en) 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
WO1998024785A1 (en) * 1996-12-02 1998-06-11 Fujisawa Pharmaceutical Co., Ltd. Indole-urea derivatives with 5-ht antagonist properties
GB9724372D0 (en) * 1997-11-18 1998-01-14 Smithkline Beecham Plc Novel compounds
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
FR2807754A1 (fr) * 2000-04-13 2001-10-19 Adir Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2837823B1 (fr) * 2002-03-27 2005-04-08 Servier Lab Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1616192A1 (en) * 2002-12-23 2006-01-18 Bayer HealthCare AG Diagnostics and therapeutics for diseases assosciated with 5-hydroxytryptamine (serotonin) receptor 2b (5-hteb)
GB0305553D0 (en) * 2003-03-11 2003-04-16 Glaxo Group Ltd Compounds
WO2014049153A1 (en) * 2012-09-28 2014-04-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonists of the 5-ht2b receptor for use in the prevention or treatment of spasticity
WO2022006365A2 (en) * 2020-07-02 2022-01-06 Purdue Research Foundation Tetrahydro-3h-pyrazolo quinolone and tetrahydro-3h-pyrrolo[3,2-f]quinoline-containing compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT98927A (pt) * 1990-09-13 1992-07-31 Beecham Group Plc Processo para a preparacao de piridil-indolil-ureias

Also Published As

Publication number Publication date
WO1994004533A1 (en) 1994-03-03
NZ254785A (en) 1995-09-26
IL106737A0 (en) 1994-05-30
MA22955A1 (fr) 1994-04-01
TW248557B (es) 1995-06-01
EP0656003A1 (en) 1995-06-07
CA2142721A1 (en) 1994-03-03
AP9300560A0 (en) 1995-02-19
AU4704693A (en) 1994-03-15
SI9300438A (en) 1994-03-31
CN1086819A (zh) 1994-05-18
JPH08500580A (ja) 1996-01-23

Similar Documents

Publication Publication Date Title
MX9305037A (es) Compuestos novedosos
EA199800664A1 (ru) Замещенные производные 4-гидрокси-фенилалкановой кислоты с агонистической активностью по отношению к ppar-гамма
AR002011A1 (es) Compuestos derivados de piperidina, sus sales y n-oxidos, procedimiento de preparacion y composiciones farmaceuticas.
AR035455A1 (es) Derivados triciclicos de alquilhidroxamato , procesos para su elaboracion, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos
HUP0000591A2 (hu) Fémproteáz inhibitor hatású piperazin-, morfolin- és tiomorfolin-származékok és alkalmazásuk gyógyszerkészítmények előállítására
ES2196806T3 (es) Derivados de fenilurea y de feniltiourea.
SE8200916L (sv) Karbostyrilderivat, forfarande for framstellning derav och hjertsterkande komposition som innehaller detsamma
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
CO4700452A1 (es) Derivados de indol
DK304289A (da) Benzenderivater
ES8604543A1 (es) Procedimiento para la obtencion de derivados piperazinicos
NZ227400A (en) Thiol-ketone and thiol-aldehyde derivatives, intermediates thereof and pharmaceutical compositions
DK420682A (da) Fremgangsmaade til fremstilling af triazoloquinazoloner eller salte deraf
AR012553A1 (es) Una composicion que posee propiedades antivirales, en base a 7h-benz (de) antracenos y las composiciones farmaceuticas que los contienen conjuntamentecon derivados de la benzantrona
FI853233A0 (fi) 1,6-naftyridinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter.
AR012216A1 (es) Derivados de piridina, el uso de los mismos como medicamentos para el tratamiento de desordenes alergicos e inflamatorios, procedimiento parasu preparacion y composicion farmaceutica que los contiene
FI860157A0 (fi) Foerfarande foer framstaellning av piperazin-1-yl-ergolin-derivat.
ES8705392A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidroisoquinolina.
NO914577L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser
MY103521A (en) Bicyclocatechol derivatives
AR024937A1 (es) Derivados de estreptograminas, su preparacion y las composiciones farmaceuticas que los contienen.
MX9307561A (es) Procedimiento para preparar lactonas.
SE7906093L (sv) Nya substituerade 4h-s-triazolo(3,4c)tieno(2,3e)-1,4-diazepiner, forfaranden for framstellning derav och farmaceutiska kompositioner
AR247731A1 (es) Procedimiento para preparar una nueva clase de nitrones ciclicos, utiles para la prevencion de danos oxidantes de tejidos debido a radicales oxigenados libres y como inhibidores interleucina-1
DK83381A (da) Fremgangsmaade til fremstilling af tetrazolderivater